Security key
07725L102
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Ordinary Shares, par value $0.0001 per share
- Total 13F shares
- 43,668,178
- Total 13F value
- $8,065,581,343
- Share change
- -2,941,025
- Put/Call ratio
- 82%
- SEC-reported price per share
- $184.71
- Number of holders
- 222
- Value change
- -$576,365,574
- Number of buys
- 103
- Number of sells
- 105
- Shares outstanding
- 1,448,910,175
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
222
Top holders
10
ONC full security history
Ownership snapshot
Full 13F holder table
BeOne Medicines Ltd. SEC filings
BeOne Medicines Ltd. company facts
BeOne Medicines Ltd. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
15/15
Latest evidence
02 Dec 2024
13F
3/4/5
Lead comparable stake: 0.73%
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 0.73%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
0.73%
Capital International Investors
0.44%
HHLR ADVISORS, LTD.
0.36%
PRIMECAP MANAGEMENT CO/CA/
0.34%
BAILLIE GIFFORD & CO
0.26%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.73%
|
$2,372,823,065
10,568,897 shares
|
— | 30 Sep 2024 |
| Capital International Investors |
13F
Company
|
0.44%
|
$1,441,427,971
6,430,884 shares
|
— | 30 Sep 2024 |
| HHLR ADVISORS, LTD. |
3/4/5
13F
10%+ Owner · Company
|
0.36%
from 13F
|
$25,009,148,200
125,045,741 shares
|
— | 02 Dec 2024 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
0.34%
|
$1,116,777,627
4,974,289 shares
|
— | 30 Sep 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
0.26%
|
$831,979,279
3,705,756 shares
|
— | 30 Sep 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
0.19%
|
$606,197,000
2,700,088 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
222
Shares
43,668,178
Rows available
222
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
221
Q4 2024 holders
222
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|